Praxis Precision Medicines’ commitment to forging ahead with ulixacaltamide in essential tremor (ET) has paid off. After brushing off a recommendation to end a phase 3 study earlier this year based on ...
Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...
The ability to store information has been an important aspect of human development. Ancient cave paintings, hieroglyphs on pyramids in Egypt, the eighth-century archival scrolls of the Shosoin ...
Department of Chemistry and Biochemistry, University of California Santa Barbara, Santa Barbara, California 93106, United States Center for Bioengineering, University of California Santa Barbara, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback